About CPC
ARO Services
Core Labs
Training
Prevention
Fundraising
Search


CPC Home Page
William R. Hiatt, MD
Bibliography
President: William R. Hiatt, MD
Chief Operating Officer: Evan King
Director of Medical Affairs: Raymond O. Estacio, MD
Director of Prevention Programs: Mori J. Krantz, MD, FACC
Director, Research Operations: Lisa Cox, MA
Founder: Robert W. Schrier, MD


William R. Hiatt, MD

Book Chapters, Reviews & Editorials:

  1. Rutherford R, Hiatt W, Kreutzer E.  The use of velocity wave form analysis in the diagnosis of carotid artery occlusive disease.  In: Diethrich E. ed.  Noninvasive Cardio­vascular Diagnosis:  Current Concepts.  University  Park Press, 1978:75‑82.
  2. Hiatt WR, Byyny R.  A general internal medicine residency training program:  Goals, objectives and a partial description.  In: Thompson T, Byyny R, eds.  The education of the general internist.  Ovid Bell Press, 1982:36‑40.
  3. Hiatt WR, Nies A.  Effect of beta blockers on peripheral vascular disease.  Cardiology Board Review 1986;3:96-99.
  4. Regensteiner JG, Hiatt WR.  Exercise guidelines for older patients.  The Older Patient 1987;1:11-18.
  5. Hiatt WR, Regensteiner J.  Peripheral vascular disease.  In: Schrier RW, ed.  Geriatric Medicine.  Philadelphia: W.B. Saunders Co., 1990:265-272.
  6. Hiatt WR, Wolfel, EE, and Regensteiner JG.  Exercise in the treatment of intermittent claudication due to peripheral arterial disease.  Vasc Med Rev 1991;2:61-70.
  7. Hiatt WR.  Exercise physiology in cardiovascular diseases.  Current Opinion in Cardiology 1991;6:745-749.
  8. Hiatt WR, Regensteiner JG.  The value of exercise programs and risk factor modifications in claudicators.  Seminars in Vascular Surgery 1991;4:188-194.
  9. Hiatt WR, Hargarten M, and Regensteiner JG.  Chronic arterial occlusive disease:  Exercise rehabilitation.  In: Cooke JP, Frohlich, ed.  Current Management of Hypertensive and Vascular Diseases.  St. Louis, Mosby Year Book Inc, 1992:208-212.
  10. Hiatt WR.  Commentary on "Intermittent claudication with b-blockers: A meta analysis."  ACP J Club. 1992 Jan/Feb (Ann Intern Med vol 116, suppl 1, page 3).
  11. Hiatt WR.  Commentary on "Does atenolol or nifedipine worsen intermittent claudication."  ACP J Club. 1992 March/April (Ann Intern Med vol 116, suppl 2, page 43).
  12. Hiatt WR and Jones DN.  The role of hemodynamics and duplex ultrasound in the diagnosis of peripheral arterial disease.  Current Opinion in Cardiology 1992;7:805-810.
  13. Hiatt WR and Regensteiner JG.  Nonsurgical management of peripheral arterial disease.  Hospital Practice  1993;28:59-82.
  14. Hiatt WR, Regensteiner JG, Wolfel EE.  Special Populations in Cardiovascular Rehabilitation.  Peripheral Arterial Disease, Non-Insulin-Dependent Diabetes Mellitus, and Heart Failure.  In, Crawford MH, Fletcher GF ed.  Cardiology Clinics.  Philadelphia, W.B. Saunders Co., 1993;11:309-21.
  15. Hiatt WR.  Medical treatment of the patient with intermittent claudication.  J Vasc Technol.  1994;18:311-315.
  16. Regensteiner JG, Hiatt WR.  Exercise rehabilitation for patients with peripheral arterial disease.  In: Holloszy JO ed.  Exercise and Sport Sciences Review, Baltimore, MD, Williams & Wilkins, 1995;23:1-24.
  17. Porter JM, ed., Callow AD, Edwards JM, Giddings AEB, Hertzer NR, Hiatt WR, Johansen K, contributing editors.  Year Book of Vascular Surgery.  St. Louis, MO, Mosby-Year Book, Inc., 1995.
  18. Hiatt WR, Brass EP.  Carnitine metabolism in peripheral arterial disease.  In: De Jong JW and Ferrari R ed.  The Carnitine System.  A New Therapeutic Approach to Cardiovascular Diseases, Dordrecht, Netherlands.  Kluwer Academic Publishers, 1995:353-363.
  19. Hiatt WR, Regensteiner J.  Peripheral arterial and venous disease.  In: Schrier RW, Jahnigen DW, ed.  Geriatric Medicine, 2nd edition.  Cambridge, MA: Blackwell Scientific Publications, Inc., 1996:502-513.
  20. Hiatt WR.  Current Recommendations for Deep-Vein Thrombosis Prophylaxis.  In: Yao JST and Pearce WH ed.  Progress in Vascular Surgery.  Stanford, CT, Appleton & Lange, 1997:499-504.
  21. Regensteiner J, Gardner A, Hiatt WR.  Exercise testing and exercise rehabilitation for patients with peripheral arterial disease:  Status in 1997.  Vasc Med 1997;2:147-155.
  22. Hiatt WR.  Intermittent Claudication:  Natural History, Medical Management, and Patient Selection for Intervention.  In Perler BA and Becker GJ ed.  Vascular Intervention.  A Clinical Approach.  New York, NY, Thieme Medical Publishers, Inc., 1998:77-83.
  23. Regensteiner JG, Hiatt WR.  Assessing functional status and quality of life in patients with claudication.  Critical Ischaemia 1998;7:79-87.
  24. Hiatt WR.  Propionyl-L-Carnitine.  A Viewpoint.  Drugs & Aging 1998;12:249-250.
  25. Regensteiner JG, Hiatt WR.  Exercise in the Management of Peripheral Arterial Disease.  In Roitman JL ed.  ACSM’s Resource Manual for Guidelines for Exercise Testing and Prescription.  Third Edition.  Baltimore, MD, Williams & Wilkins, 1998:281-287.
  26. Hiatt WR.  Nonoperative, Nonpharmacologic Management of Lower Extremity Occlusive Disease.  In: Ernst C and Stanley J ed.  Current Therapy in Vascular Surgery.  Philadelphia, PA, 1998.
  27. Hiatt WR.  Introduction and Overview.  In: Hirsch, AT and Hiatt WR ed.   The American Journal of MedicineContinuing Education Series, Part IV: Morbitity of PAD: Medical Approaches to Claudication.  June 1999
  28. Hiatt WR.  Medical Treatment of Claudication.  In: Hirsch, AT and Hiatt WR ed.   The American Journal of MedicineContinuing Education Series, Part IV: Morbitity of PAD: Medical Approaches to Claudication.  June 1999
  29. Hiatt WR.  Peripheral Arterial Disease: Cost-Effective Diagnosis and Management.  In: Schrier RW, Mehler PS ed.  Primary Care Case Reviews, Volume 2, Number 3, pp. 145-155, September 1999.
  30. Hiatt WR.  Atherosclerotic Peripheral Artery Disease.  In: Goldman L and Bennett JC ed.  Cecil Textbook of Medicine, Twenty-First Edition.  Orlando, FL, W.B. Saunders Company, 2000:357-362.
  31. Hiatt WR.  Re: Expression of myosin heavy chain isoforms in skeletal muscle of patients with peripheral arterial occlusive disease.  J Vasc Surg 2000;31(3):611-612.
  32. Hiatt WR, Cooke JP.  Atherogenesis and the Medical Management of Atherosclerosis.  In: Rutherford RB ed.  Vascular Surgery.  Fifth Edition.  Philadelphia, PA, W.B. Saunders Company, 2000:333-350.
  33. Brass EP, Hiatt WR, Nehler MR.  Peripheral Arterial Disease.  In: Wachter RM, Goldman L, and Hollander H ed.  Hospital Medicine.  Philadelphia, PA, Lippincott Williams & Wilkins, 2000:339-346.
  34. Hiatt, WR.  Therapeutic Approaches to Intermittent Claudication.  In: Management of Peripheral Arterial Disease for the Primary Care Physician: Focus on Intermittent Claudication.  Supplement to Family Practice Certification.  May 15, 2000; 22(7):13-18.
  35. Hiatt WR.  Pathophysiology.  In: Management of Peripheral Arterial Disease.  Medical, Surgical and Interventional Aspects.  Creager MA ed.  REMEDICA Publishing Limited, 43-56, Oct. 2000.
  36. Hiatt WR, Nehler MR.  Management of Hyperlipidemia, In: Cronenwett JL and Rutherford RR ed.  Decision Making in Vascular Surgery. Philadelphia, PA, W.B. Saunders Company, 2001:6-7.
  37. Dawson DL, Hiatt WR, Creager MA, Hirsch AT.  Peripheral Arterial Disease: Medical Care and Prevention of Complications.  Preventive Cardiology.  In press.
  38. Hiatt WR.  Nonoperative, Nonpharmacologic Management of Lower Extremity Occlusive Disease.  In: Ernst C and Stanley J ed.  Current Therapy in Vascular Surgery.  Fourth Ed. Mosby, Inc., 2001.
  39. Hiatt WR.  Re:  Gadolinium-enhanced magnetic resonance angiography is highly sensitive and specific for peripheral arterial disease.  ACP Journal Club, Jan/Feb 2001; 134(1):27.
  40. Hiatt WR, Nehler MR.  Peripheral Arterial Disease.  In: Schrier RW ed. Advances in Internal Medicine, Vol 47, December 2001, Mosby, Inc.
  41. Hiatt WR.  Pathophysiology.  In: Creager M ed.  Management of Peripheral Arterial Disease: Medical , Surgical and Interventional Aspects.  ReMEDICA Publishing Ltd.  October, 2000.
  42. Hiatt WR.  New treatment options in intermittent claudication: The U.S. experience.  International Journal of Clinical Practice, Supplement 119, April 2001, pp 20-27.
  43. Hiatt WR and Regensteiner JG.  The value of risk factor modification and exercise programs in claudicators.  Semin. Vasc. Surg 2001;4:188-194.
  44. Bauer TA, Hiatt WR.  Exercise Rehabilitation for Intermittent Claudication.  In: Coffman J and Eberhardt R eds. Peripheral Arterial Disease: Diagnosis and Treatment.  The Humana Press, Inc., October, 2002.
  45. Bauer TA, Hiatt WR.  Exercise gas exchange in peripheral arterial disease.  In: Wasserman K. ed. Cardiopulmonary Exercise Testing and Cardiovascular Health, 2002.  Futura Publishing Co. pp191-197.
  46. Hiatt WR.  Atherosclerotic Peripheral Artery Disease.  In: Goldman L and Bennett JC ed.  Cecil Textbook of Medicine, 22nd Edition.  Orlando, FL, W.B. Saunders Company, October, 2003.
  47. Hiatt WR, Nehler MR.  Peripheral Arterial Disease.  In: Cassel C, Leipzig R, Cohen H, Larson E, Meier D.  Geriatric Medicine.  An Evidence-based approach.  New York, Springer-Verlag, 2003.  pp 561-571.
  48. Hiatt WR, Mohler EM.  Peripheral Vascular Disease.  In: Gerstenblith G ed.  Cardiovascular Disease in the Elderly.  The Humana Press, Inc.  In development.
  49. Hiatt, WR.  Consultations on Patients with Venous or Arterial Diseases.  Evaluation of Patients with Peripheral Vascular Disease.  American Society of Hematology Education Program Book, 2003 pp 546-550.
  50. Hiatt, WR, Baumgartner Iris, Bluemke DA.  Peripheral Manifestations of Atherothrombosis.  Atlas of Atherothrombosis  Topol EJ  ed. Science Press Ltd. 2004;5:109-136.
  51. Brass EP, Hiatt WR, Nehler M:  Peripheral arterial disease. In Hospital Medicine, 2nd Edition.  (Wachter RM, Goldman L, Hollander H, eds.)  Lippincott, Williams and Wilkins, Baltimore pp. 485-493, 2005.
  52. Hiatt WR.  Invited commentary regarding Spring et al “Decreased wall shear stress in the common carotid artery  in patients with peripheral arterial disease or abdominal aortic aneurysm:  Relation to blood rheology, vascular risk factors, and intima-medial thickness. J Vasc Surg 2006;43:63.
  53. Graystone JT, Campbell LA, Crouse JR, Hiatt WR.  Infectious contributions to atherosclerosis and vascular disease:  Do we really know the answer?  Vascular Disease Management 2006; 290-299

< TOP >


Copyright © 2002-2007 Colorado Prevention Center
All Rights Reserved
Terms and Privacy Information  		Developed by Ibis Computer Consulting